Table 1 Demographic data, risk factors, cardiovascular history and presenting characteristics of patients with and without chronic oral anticoagulant drug treatment (COA).
| No COA group (n = 2019 (96%)) | COA group (n = 93 (4%)) | p Value | |
|---|---|---|---|
| Demographic data | |||
| Age (years) | 66 (52–76) | 76 (71–83) | <0.001 |
| Men | 1469 (73%) | 60 (65%) | 0.105 |
| Risk factors | |||
| Hypertension | 949 (47%) | 60 (65%) | 0.001 |
| Diabetes mellitus | 390 (19%) | 34 (37%) | <0.001 |
| BMI (kg/m2) | 26.2 (23.8–29.1) | 25.8 (23.5–28.8) | 0.559 |
| Hypercholesterolaemia | 804 (40%) | 46 (49%) | 0.081 |
| Current smoking | 664 (33%) | 12 (13%) | <0.001 |
| Cardiovascular history | |||
| MI | 226 (11%) | 31 (33%) | <0.001 |
| Stroke | 93 (5%) | 12 (13%) | <0.001 |
| PAD | 138 (7%) | 12 (13%) | 0.043 |
| Presenting characteristics | |||
| TIMI score | 3 (2–5) | 6 (4–7) | <0.001 |
| Killip >I | 418 (21%) | 37 (40%) | <0.001 |
| DBP (mm Hg) | 80 (69–90) | 80 (70–90) | 0.577 |
| SBP (mm Hg) | 133 (117–153) | 131 (120–153) | 0.915 |
| HR (beats/min) | 78 (65–90) | 78 (66–94) | 0.515 |
| Anterior MI | 875 (43%) | 45 (48%) | 0.394 |
| LVEF (%) | 52 (43–62) | 45 (35–52) | <0.001 |
| Time to admission (min) | 209 (104–580) | 250 (120–607) | 0.497 |
Data are number (%) or median (interquartile range).
BMI, body mass index; DBP, diastolic blood pressure; HR, heart rate; LVEF, left ventricular ejection fraction; MI, myocardial infarction; PAD, peripheral arterial disease; SBP, systolic blood pressure; TIMI, thrombolysis in myocardial infarction.